Identification of a molecular signature for antipsychotics and SERMs

Details for Australian Patent Application No. 2009246120 (hide)

Owner Vanda Pharmaceuticals, Inc.

Inventors Lavedan, Christian; Polymeropoulos, Mihael H.; Licamele, Louis

Agent Pizzeys

Pub. Number AU-A-2009246120

PCT Pub. Number WO2009/140665

Priority 61/054,086 16.05.08 US

Filing date 15 May 2009

Wipo publication date 19 November 2009

International Classifications

A61K 31/00 (2006.01)

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 5/30 (2006.01) Drugs for disorders of the endocrine system

A61P 5/32 (2006.01) Drugs for disorders of the endocrine system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/92 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/140665 Priority application(s): WO2009/140665

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009246128-Thermal compress system and methods of using the same

2009246116-Method of preventing premature delivery